SHSE:603235 (China)
Â
Class A
Â¥
26.16
(-0.04%)
Dec 27
Business Description
JiangXi Tianxin Pharmaceutical Co Ltd
ISIN : CNE100005Q89
Share Class Description:
SHSE:603235: Class ACompare
Compare
Traded in other countries / regions
603235.China IPO Date
2022-07-12Description
JiangXi Tianxin Pharmaceutical Co Ltd is engaged in the research and development, production and sales of monomeric vitamin products.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 16.32 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.16 | |||||
| Interest Coverage | 16.76 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 10.26 | |||||
| Beneish M-Score | -2.09 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -9.6 | |||||
| 3-Year EBITDA Growth Rate | -17.8 | |||||
| 3-Year EPS without NRI Growth Rate | -24.2 | |||||
| 3-Year FCF Growth Rate | -41.2 | |||||
| 3-Year Book Growth Rate | 48.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.12 | |||||
| 9-Day RSI | 44.26 | |||||
| 14-Day RSI | 45.88 | |||||
| 6-1 Month Momentum % | 7.82 | |||||
| 12-1 Month Momentum % | 15.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.82 | |||||
| Quick Ratio | 6.39 | |||||
| Cash Ratio | 5.04 | |||||
| Days Inventory | 142 | |||||
| Days Sales Outstanding | 42.23 | |||||
| Days Payable | 40.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.91 | |||||
| Dividend Payout Ratio | 0.38 | |||||
| Forward Dividend Yield % | 1.91 | |||||
| 5-Year Yield-on-Cost % | 1.91 | |||||
| 3-Year Average Share Buyback Ratio | -3.6 | |||||
| Shareholder Yield % | 1.26 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 42.66 | |||||
| Operating Margin % | 29.42 | |||||
| Net Margin % | 27.76 | |||||
| FCF Margin % | -18.32 | |||||
| ROE % | 12.94 | |||||
| ROA % | 10.91 | |||||
| ROIC % | 18.41 | |||||
| ROC (Joel Greenblatt) % | 31.65 | |||||
| ROCE % | 14.66 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 20.45 | |||||
| PE Ratio without NRI | 19.78 | |||||
| PS Ratio | 5.68 | |||||
| PB Ratio | 2.57 | |||||
| Price-to-Tangible-Book | 2.68 | |||||
| Price-to-Operating-Cash-Flow | 19.55 | |||||
| EV-to-EBIT | 14.21 | |||||
| EV-to-EBITDA | 14.21 | |||||
| EV-to-Revenue | 4.89 | |||||
| EV-to-FCF | -27.01 | |||||
| Price-to-Graham-Number | 1.54 | |||||
| Price-to-Net-Current-Asset-Value | 6.06 | |||||
| Price-to-Net-Cash | 12.34 | |||||
| Earnings Yield (Greenblatt) % | 7.04 | |||||
| FCF Yield % | -3.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
JiangXi Tianxin Pharmaceutical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,008.233 | ||
| EPS (TTM) (Â¥) | 1.28 | ||
| Beta | 0 | ||
| Volatility % | 37.17 | ||
| 14-Day RSI | 45.88 | ||
| 14-Day ATR (Â¥) | 0.644475 | ||
| 20-Day SMA (Â¥) | 26.488 | ||
| 12-1 Month Momentum % | 15.63 | ||
| 52-Week Range (Â¥) | 19.13 - 32.06 | ||
| Shares Outstanding (Mil) | 437.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
JiangXi Tianxin Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
JiangXi Tianxin Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
JiangXi Tianxin Pharmaceutical Co Ltd Frequently Asked Questions
What is JiangXi Tianxin Pharmaceutical Co Ltd(SHSE:603235)'s stock price today?
The current price of SHSE:603235 is ¥26.16. The 52 week high of SHSE:603235 is ¥32.06 and 52 week low is ¥19.13.
When is next earnings date of JiangXi Tianxin Pharmaceutical Co Ltd(SHSE:603235)?
The next earnings date of JiangXi Tianxin Pharmaceutical Co Ltd(SHSE:603235) is .
Does JiangXi Tianxin Pharmaceutical Co Ltd(SHSE:603235) pay dividends? If so, how much?
The Dividend Yield %  of JiangXi Tianxin Pharmaceutical Co Ltd(SHSE:603235) is 1.91% (As of Today), Highest Dividend Payout Ratio of JiangXi Tianxin Pharmaceutical Co Ltd(SHSE:603235) was 0.72. The lowest was 0.38. And the median was 0.72. The  Forward Dividend Yield % of JiangXi Tianxin Pharmaceutical Co Ltd(SHSE:603235) is 1.91%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers